Pune, India

Haresh Ishwarbhai Patel

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Haresh Ishwarbhai Patel: Innovator in Pharmaceutical Formulations

Introduction

Haresh Ishwarbhai Patel is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in drug formulation. With a total of two patents to his name, Patel is recognized for his innovative approaches to cancer treatment.

Latest Patents

Patel's latest patents include a Carmustine formulation and a liquid formulation of Cabazitaxel. The Carmustine formulation relates to a composition comprising nitrosourea and pharmaceutically acceptable excipients. This invention focuses on novel drug delivery systems of Carmustine, such as nano-suspension and micro-emulsion, aimed at treating cancer through intravenous administration. Additionally, he has developed a stable liquid formulation of Cabazitaxel, which includes cabazitaxel and at least one solubilizer. These formulations are typically available as ready-to-use solutions or concentrates.

Career Highlights

Haresh Patel is currently associated with Emcure Pharmaceuticals Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in drug formulation has positioned him as a valuable asset in the industry.

Collaborations

Patel collaborates with talented professionals in his field, including Hiren Pravinbhai Patel and Deepak Pragjibhai Gondaliya. Their combined efforts contribute to the advancement of pharmaceutical innovations.

Conclusion

Haresh Ishwarbhai Patel is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact cancer treatment. His innovative patents reflect his commitment to improving drug delivery systems and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…